Evidence map›Paper›PMID 23104934›Full record

ArticleExperimental physiology2013

Bradycardic effects mediated by activation of G protein-coupled estrogen receptor in rat nucleus ambiguus.

G Cristina Brailoiu, Jeffrey B Arterburn, Tudor I Oprea, Vineet C Chitravanshi, Eugen Brailoiu

Open access · bronzeAbstract read
In one paragraph

Article in Experimental physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Sex-steroid-dependent plasticity of brain-stem autonomic circuits.American journal of physiology. Regulatory, integrative and comparative physiology · 2020
    Review
  5. Article
  6. Central serotonin and the control of arterial blood pressure and heart rate in infant rats: influence of sleep state and sex.American journal of physiology. Regulatory, integrative and comparative physiology · 2018
    Article
  7. Activation of GPER ameliorates experimental pulmonary hypertension in male rats.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2017
    Article
  8. GPER-novel membrane oestrogen receptor.Clinical science (London, England : 1979) · 2016
    Review
  9. Article
  10. Evidence for role of acid-sensing ion channels in nucleus ambiguus neurons: essential differences in anesthetized versus awake rats.Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2014
    Article
  11. HIV-1-Tat excites cardiac parasympathetic neurons of nucleus ambiguus and triggers prolonged bradycardia in conscious rats.American journal of physiology. Regulatory, integrative and comparative physiology · 2014
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

G Cristina BrailoiuNeurological Surgery, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, USA.
Jeffrey B Arterburn
Tudor I Oprea
Vineet C Chitravanshi
Eugen Brailoiu
Neurological Surgery · USNew Mexico State University · USTemple University · USThomas Jefferson University · USUniversity of New Mexico · US

Funding

Development of GPR30-Selective LigandsR01CA127731 · NCI · UNIVERSITY OF NEW MEXICO · PI ARTERBURN, JEFFREY B, OPREA, TUDOR I · 2008 to 2012
$1.7M
Role of nonnuclear estrogen receptor GPR30 in preganglionic vagal neuronsR01HL090804 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI BRAILOIU, EUGEN · 2009 to 2012
$1.5M
NCI NIH HHS CA127731NCI NIH HHS R01 CA127731NHLBI NIH HHS HL090804NHLBI NIH HHS R01 HL090804
6 · The paper itself

Abstract

The G protein-coupled estrogen receptor (GPER) has been identified in several brain regions, including cholinergic neurons of the nucleus ambiguus, which are critical for parasympathetic cardiac regulation. Using calcium imaging and electrophysiological techniques, microinjection into the nucleus ambiguus and blood pressure measurement, we examined the in vitro and in vivo effects of GPER activation in nucleus ambiguus neurons. A GPER selective agonist, G-1, produced a sustained increase in cytosolic Ca(2+) concentration in a concentration-dependent manner in retrogradely labelled cardiac vagal neurons of nucleus ambiguus. The increase in cytosolic Ca(2+) produced by G-1 was abolished by pretreatment with G36, a GPER antagonist. G-1 depolarized cultured cardiac vagal neurons of the nucleus ambiguus. The excitatory effect of G-1 was also identified by whole-cell visual patch-clamp recordings in nucleus ambiguus neurons, in medullary slices. To validate the physiological relevance of our in vitro studies, we carried out in vivo experiments. Microinjection of G-1 into the nucleus ambiguus elicited a decrease in heart rate; the effect was blocked by prior microinjection of G36. Systemic injection of G-1, in addition to a previously reported decrease in blood pressure, also reduced the heart rate. The G-1-induced bradycardia was prevented by systemic injection of atropine, a muscarinic antagonist, or by bilateral microinjection of G36 into the nucleus ambiguus. Our results indicate that GPER-mediated bradycardia occurs via activation of cardiac parasympathetic neurons of the nucleus ambiguus and support the involvement of the GPER in the modulation of cardiac vagal tone.

Indexed as

AnimalsBradycardiaCalciumCyclopentanesHeartMaleMedulla OblongataMembrane PotentialsParasympathetic Nervous SystemQuinolinesRatsRats, WistarReceptors, EstrogenReceptors, G-Protein-CoupledVagus Nerve1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanoneCalciumCyclopentanesQuinolinesReceptors, EstrogenReceptors, G-Protein-Coupled

Identifiers

PMID23104934
PMCPMC3578005
OpenAlexW2147381969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.